PTC Therapeutics Phase 2 Data from Spinal Muscular Atrophy Program to be Presented at 20th International Annual Congress of WMS

By: via Benzinga
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that clinical data from the company's joint development program with Roche and the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.